Whereas the 5′UTR and 3′UTR of the BRCA1/2 genes have been two of the most intensely investigated non–coding regions over the last few years [12,13,31,32,33,34], this is the first fully comprehensive study of 5′and 3′UTRs of so called “minor genes for breast/ovarian cancer susceptibility” and a number of variants were also identified in the 5′UTRs: 4 in the PTEN gene and 3 in the RAD51C gene and the in-silico predictions obtained regarding their involvement in TF binding are interesting (Table S2a in Supplementary Materials). The gene discussed is BRCA1; the disease is ovarian cancer.